Class / Patent application number | Description | Number of patent applications / Date published |
424642000 | For topical application | 65 |
20080206357 | VIF as a traget for HIV inhibition - The present invention relates, e.g., to a method for inhibiting infectivity of a lentivirus (e.g., a lentivirus which expresses a Viral infectivity factor (Vif) protein), such as, e.g., SIV, SHIV and/or HIV, comprising contacting a cell which is producing the virus with an antiviral-effective amount of a membrane-permeable Zinc (Zn) chelator, wherein the antiviral-effective amount of the Zn chelator does not substantially inhibit proteins in the cell which contain Zn-binding motifs other than lentivirus Vif. Kits and pharmaceutical compositions are also disclosed, as is a method for identifying inhibitors of lentiviruses that target a specific zinc-binding motif of the lentivirus Vif protein. | 08-28-2008 |
20080213398 | Modified Azole Compounds as Antifungal and Antibacterial Agents - The present invention relates to the compounds of formula (I), their preparation and use as antifungal and/or antibacterial agents. | 09-04-2008 |
20080220091 | REDUCTION OF REACTIVE OXYGEN SPECIES IN CHRONIC WOUND MANAGEMENT - Reactive oxygen species associated with a wound are modulated through treatment of the wound with a solution of metal ions selected from the group consisting of potassium ions, zinc ions, calcium ions and rubidium ions, at a pH of between about 5 and about 7. Preferably, citric acid is employed to adjust the pH of the solution. Application of the extract to a wound exhibiting superoxide anions has been found to be effective in the treatment of these wounds through the reduction of the level of superoxide anions. Moreover, treatment of partial thickness excision wounds as well as contact burn wounds with the present composition has been found to improve epithelialization of these wounds. In addition to the antioxidant activity of the present invention, treatment of the wound employing the present composition produces inhibitory effects on ROS production by human PMNs and on human complement activation, and therefore, is further beneficial in chronic wound management. | 09-11-2008 |
20080241272 | Composition for Prevention and Treatment of Stretch Mark Comprising Citric Acid, Zinc and Arginine - Disclosed is a composition for preventing and treating stretch marks, including citric acid, zinc and arginine as active components. The composition is applicable to lesions after being formulated as a topically applied medicament or cosmetic product. The active components of the present invention, which are easily obtainable from natural sources, are safe to the body and are capable of preventing and treating stretch marks even in small amounts. | 10-02-2008 |
20080274209 | METHODS OF TREATING INFLAMMATION - Disclosed are compositions containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients), and a pharmaceutical carrier. Also disclosed are methods of treating inflammatory symptoms and lesionous symptoms of a viral infection involving applying an effective amount of the pharmaceutical composition to the inflammation and lesions. | 11-06-2008 |
20080292725 | COPPER-FREE FOOTBATH BLEND - Provided is a composition suitable for treating a foot of an animal. The composition comprises zinc sulfate monohydrate, a chloride salt, and an acid, wherein the composition does not comprise copper. Also provided is a method for treating a foot of an animal. The method comprising contacting the foot of the animal with the above composition. | 11-27-2008 |
20090035392 | User-adjustable treatment methods, systems and compositions for treating acne - Methods, apparatus, systems and the like for treating acne vulgaris that improves treatment effectiveness and/or reduces bothersome side effects associated with the ingredients used. The present Methods, apparatus, systems, etc., also provide topical compositions of benzoyl peroxide and/or other anti-acne agents that are useful for treating acne vulgaris and may be used simultaneously or sequentially in a user-adjustable ratio of two or more such compositions, or other compositions as desired such as cleansers or lotions. | 02-05-2009 |
20090104284 | Topically Applied Chitosan Composition for Pain Relief and Boosting Immune System - A composition of matter that when applied topically relieves pain in the area where it is applied (i.e. knees, back, elbows, heels, etc.). The composition contains chitosan, canola oil, sea salt minerals (chloride ion, sulfate ion, calcium, potassium, zinc, sodium, magnesium and nickel), and water. To make the composition, the ingredients should be at room temperature. Dissolve 7-8 grams of medical grade or edible grade chitosan in 1 liter of canola oil. Dissolve 2 tsp of sea salt containing the following minerals (chloride ion, sulfate ion, calcium, potassium, zinc, sodium, magnesium and nickel) in 50ml of distilled water. Pour the sea salt solution into the chitosan-canola oil mixture. The chitosan-canola oil is hydrophilic and absorbs the sea salt water into the composition negating the water-oil interface. Shake well for 10 minutes or mechanically blend for 5 minutes. Apply generously to skin over affected area. The same ratios apply to larger batches. The chitosan-oil-water-mineral composition permits the ingredients to cross tissue barriers to effect skin, connective tissue, tendon, ligaments, cartilage and bone to relieve pain, stop inflammation and heal inflamed underlying tissue. The respective components of the chitosan-oil-water-mineral composition will not cross the pericutaneous tissue barriers alone. | 04-23-2009 |
20090123564 | NOVEL COMPOSITIONS FOR HAIR DISORDERS AND PROCESS OF PREPARATION THEREOF - Novel compositions for hair loss prevention and/or hair growth promotion comprising at least active agent preferably derived from natural source such as from the plant | 05-14-2009 |
20090142412 | Skin Care Cosmetic Cream/Scrub Product - A series of cosmetic scrubs and creams, some containing coffee, have the ability to moisturize, soften, scrub and revitalize body parts, create natural tanning qualities, and sooth itch from burns and bug bites. | 06-04-2009 |
20090155383 | Personal Care Compositions Comprising Undecyl Sulfates - A personal care composition utilizing undecyl sulfates and/or ethoxylated undecyl sulfates (undeceth sulfates). | 06-18-2009 |
20090169644 | Antidandruff Shampoo - Surfactant-containing cleansing compositions contain hydrogenated castor oil for stabilizing an antidandruff component that is insoluble in the cleansing composition. As a result, thorough and gentle cleansing of skin and/or of hair with simultaneous antidandruff effect is ensured, without phase separation, change in viscosity, or reduction in the foaming ability during storage. Optimally, it is possible to dispense with additional stabilization of the antidandruff component through the use of gel formers. | 07-02-2009 |
20090297626 | Methods for preparing metal oxides - The disclosed subject matter provides a method for preparing a metal oxide, the method includes (a) contacting a metal salt precursor with an alcohol to provide a metal oxide; and (b) removing the metal oxide from the alcohol. | 12-03-2009 |
20100021563 | COMPOSITIONS COMPRISING COCONUT OIL AND METHODS OF USE THEREOF - The present disclosure relates to natural and/or homeopathic compositions comprising coconut oil in a form suitable for topical administration to a subject and having one or more health-promoting property, including those for treatment and/or prevention of disease, and methods for use thereof. The present disclosure further relates to natural and/or homeopathic compositions comprising coconut oil and optionally at least one additional active agent, which may impart natural, homeopathic, medicinal, pharmaceutical, and/or cosmetic properties, and methods for use thereof. | 01-28-2010 |
20100129468 | ANTIFUNGAL FOAM CONTAINING CICLOPIROXOLAMINE AND ZINC PYRITHIONE AND MEDICAL AND COSMETIC APPLICATIONS THEREOF - The invention relates to a composition in the form of an emulsion that can be expanded by an aerosol dispenser, characterised in that it comprises from 15 to 20 volume % of alcohol, from 1 to 10 volume % of C | 05-27-2010 |
20100151046 | Disinfectant - A disinfectant comprising the following (a), (b), (c) and (d), but no other microbicidal disinfecting agents intended for microbicidal disinfection: | 06-17-2010 |
20100151047 | EFFECT PIGMENTS - Disclosed are yellowing-stable, silver-white effect pigments having high whiteness based on synthetic mica flakes and to the use thereof in paints, lacquers, printing inks, plastics, button pastes, ceramic materials, glasses, for coloring seed, as dopant in laser markings of plastics and papers, as additive for laser welding of plastics, as additive for coloring in the foods and pharmaceuticals sectors and in cosmetic formulations, and for the preparation of pigment compositions and dry preparations. | 06-17-2010 |
20100151048 | TOPICAL COMPOSITION AND METHOD FOR THE TREATMENT AND PROPHYLAXIS OF DERMAL IRRITATIONS - A composition and method for the prevention and therapeutic treatment of skin conditions and disorders are disclosed. The composition and method of the invention are particularly directed to the treatment and prevention of dermal irritations. These irritations include, for example, psoriasis, eczema, ichthyosis, pruritus, dryness and dermatitis, which may cause skin to crack, chap or chafe. The composition and method are particularly useful in treating and preventing diaper dermatitis. A therapeutic composition according to the invention includes an agent, which is an enzyme constituent, promoting the synthesis of collagen and the reproduction of cells, particularly skin cells. Such therapeutic agents include, for example, zinc oxide. This agent is generally nonprescription and capable of effectively preventing and treating diaper dermatitis through local or topical application. Therapeutic compositions according to the invention also include both natural and synthetic components, which aid in application, use and treatment. | 06-17-2010 |
20100183741 | DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE - Dermatological compositions contain, formulated into a physiologically acceptable medium, at least one retinoid compound selected from among all-trans retinoic acid, isotretinoin, motretinide, and naphthoic acid compounds of formula (I), and salts and esters thereof: | 07-22-2010 |
20100196507 | Treatment of Wounds and Compositions Employed - A synthesized composition containing zinc ions, calcium ions, rubidium ions and/or potassium ions in a pharmaceutically acceptable carrier, which, when applied to an open wound, effectively modulates the activity of at least MMP-2 and/or MMP-9 in the wound. A method for treatment of wounds is disclosed. | 08-05-2010 |
20100227003 | Self-Preserving Compositions - The invention provides self-preserving compositions and methods for their production. | 09-09-2010 |
20100233291 | Animal lesion treatment and prevention formulations and methods - An illustrative embodiment of an animal lesion treatment and prevention formulation includes a quantity of water, at least one acid provided in the quantity of water and magnesium sulfate as acid/base buffer mixed in the quantity of water with the at least one acid. In some embodiments, an antimicrobial agent comprising at least one antimicrobial metal salt may be provided in the quantity of water with the at least one acid and the magnesium sulfate. | 09-16-2010 |
20100233292 | Germicidal composition - A germicidal lotion composition for treating or preventing diseases and wounds in humans or animals made by combining an aqueous phase comprising an aqueous solution or suspension containing a medicament, wherein the medicament is present in the solution or suspension in the range of about 0.015 to 80.0 wt. %; and an oil phase comprising an oil solution or suspension and a surfactant, wherein the surfactant is present in the oil in the range of from about 30 to 90 wt. %; wherein the aqueous phase is added to the oil phase in a weight ratio of about 3:1 to 99:1, and wherein the aqueous phase is added to the oil phase using low to medium shear mixing to provide the lotion. | 09-16-2010 |
20110070316 | Antimicrobial Compositions Containing Synergistic Combinations of Quaternary Ammonium Compounds and Essential Oils and/or Constituents Thereof - The present invention relates to compositions comprising quaternary ammonium compounds and essential oils or individual constituents thereof which exhibit enhanced antimicrobial effects. Such combinations may be comprised in lotions, gels, creams, soaps, etc. for application to skin or mucous membranes. The invention is based, at least in part, on the observation that synergistic antimicrobial effects are achieved with combinations of essential oils or individual constituents thereof and low concentrations of quaternary ammonium compounds. | 03-24-2011 |
20110086109 | LOW ETHER COMPOSITIONS AND DELIVERY APPARATUS - A low ether gel composition for application to skin comprising a keratolytic agent, in particular salicylic acid, and comprising a nitrocellulose and one or more volatile ingredients, which forms a film on contact with skin adequate to form a protective barrier for the keratolytic agent for a period of time necessary to provide treatment to the skin; methods of treating using such compositions, and dispensers containing such compositions. | 04-14-2011 |
20110129547 | PREPARATION FOR CARE AND PROTECTION OF SKIN WITH CHILDREN AND ADULTS, METHOD FOR OBTAINING THEREOF - Preparation for care and protection of skin with children and adults, i.e. method for obtaining thereof consists in that the zinc oxide and powder resolve in paraffin oil during 1-2 minutes up to the complete homogenization, so that these substances can be homogenized and prepared for combining merging with other substances. In the following step the water-free lano-line and white Vaseline are melted and dissolved at the same temperature of about 65% and poured into duplicate unit. Moreover in such a way melted lanoline and Vaseline, paraffin oil is added, mixture of zinc oxide and powder previously dissolved in paraffin oil and citric acid, hence the cooled mass is added. Bisabolol and bitter almond water, with constant mixing up the complete homogenization of mass, i.e. obtaining the consistency of ointment. Preparation obtained by this procedure is cooled and a slight yellowish ointment with fine almond fragrance is obtained. | 06-02-2011 |
20110206778 | Treatment For Neuropathy, Shingles And Related Disorders - A zinc oxide treatment for neuropathy, shingles, dermatitis and shingles. The treatment is applied as a cream having an active ingredient of approximately 25%, or more, zinc oxide mixed with a suitable excipient such as baby oil or petroleum jelly. The zinc oxide acts as a therapeutic agent, a sun blocking agent, and a topical anesthetic that allows the effected area to be protected. | 08-25-2011 |
20110229584 | Compound for the control of herpes simplex virus using glycyrrhizic acid, lipoic acid, allantoin, and slippery elm - A Theraputic composition of glycyrrhizic acid, slippery elm, zinc oxide, allantoin, lysine monohydrochloride, L-Carnitine, Lipoic acid, Salicylic Acid, Citric Acid, vitamin E Acetate, wheat germ oil, and Shea butter for the treatment of HSV-1, HSV-2, canker sores, shingles, and other epidermal and oral ailments. | 09-22-2011 |
20110250293 | Present invention relates to compositions and methods for the treatment of topical skin conditions, comprising of shea butter, jojoba oil, dihydrogen oxide, Stearic acid, Anhydrous Magnesium Sulphate, Zinc Oxide, Glycerin and a suitable amount of a Pharmaceutically acceptable carrier, one or both of the following: Cocoa butter and or petroleum jelly. - The present invention relates to compositions and methods for the treatment of topical skin conditions, comprising of shea butter, jojoba oil, dihydrogen oxide, Stearic acid, Anhydrous Magnesium Sulphate, Zinc Oxide, Glycerin and a suitable amount of a pharmaceutically acceptable carrier, one or both of the following: Cocoa butter and or petroleum jelly. | 10-13-2011 |
20110280962 | METALLIZATION DEVICE AND METHOD - The present invention concerns a topical formulation for the treatment of cellulite, comprising alfalfa herb and derivatives thereof and can further comprise melatonine. | 11-17-2011 |
20110318428 | TREATMENT SOLUTION FOR TREATING WOUNDS, IN PARTICULAR FOR LIQUID WOUND TREATMENT - The invention relates to a treatment solution for treating wounds, preferably for liquid wound treatment of acute and chronic wounds, made of an aqueous solution including zinc, iron, and acid, wherein the per liter proportion of zinc is 10 to 100 mg, the proportion of iron is 6.5 to 60 mg, and the proportion of acid is selected such that the pH value of the treatment solution is 2.5 to 3.5. | 12-29-2011 |
20120040019 | Medicated ointment for treating hemorrhoid and method of using the same - This invention relates to an externally applied ointment that aids in relieving irritation, pain or mild inflammation of the skin or mucous membranes associated with hemorrhoids and the method of using such ointment lotion. The formulation of the present invention contains phenylephrine HCl, lidocaine grape skin/seed/leaf extract and aloe plants extract. | 02-16-2012 |
20120082735 | Allergic skin desease topical cream - Disclosed is a cream formulation containing calamine, an H1 antihistamine, and a corticosteroid for the reduction of inflammation, redness and itching associated with acute and chronic allergic skin disease. | 04-05-2012 |
20120237613 | FACE CREAM - A face and neck cream comprised of Zinc Oxide, Virgin Olive Oil, Coconut oil, Vaseline, and 100% Pure Essential Lemon Oil, and made by mixing, placing in the composition in the microwave oven for 1.5 minutes, allowing the composition to cool for one hour, placing the composition back in the microwave oven for another 1.5 minutes, then allowing the composition to cool to allow for a thicker consistency. | 09-20-2012 |
20120308667 | EFFECT PIGMENTS - The present invention relates to effect pigments based on uncoated or coated flake-form substrates having an outer coating comprising a) TiO | 12-06-2012 |
20130004590 | ZINC OXIDE/ACID CONTAINING COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING ENZYMATIC IRRITATION - Compositions and methods for treating and/or preventing conditions such as diaper rash and atopic dermatitis are disclosed. The compositions and methods are particularly useful in the treatment and prevention of diaper rash and diaper dermatitis caused by the prolonged contact of human skin with body waste. The methods employ the topical application of a trypsin-inhibiting agent to the area in need of such treatment, or the area where prevention is desired. The trypsin-inhibiting agent is preferably zinc oxide in combination with an acid so as to release a specified divalent cation, i.e., zinc. | 01-03-2013 |
20130011494 | COMPOSITION FOR TREATING DECUBITUS ULCERS IN DIABETIC AND NON-DIABETIC PATIENTS - The various embodiments herein disclose a composition in the form of an ointment for treating decubitus ulcers in diabetic and non diabetic patients. The composition comprises of therapeutic agents, zinc oxide, vegetable oils and powdered talc. The therapeutic agents include salts of nystatin, tetracycline and neomycin, respectively. The vegetable oils include an olive oil, a soya oil and a sweet almond oil. The composition is effective in treatment of bed sore ulcers or decubitus ulcers in, both diabetic and non-diabetic patients. A method is also provided for preparing a composition in the form of an ointment for treating decubitus ulcers. | 01-10-2013 |
20130028986 | Pharmaceutical Compositions - A composition comprising a pharmaceutically acceptable group (2, 4, 12, 13 or 14) metal compound for the treatment of a dermatological condition involving an abnormal decrease in the cell-to-cell adhesion between epithelial cells in the epidermal barrier. | 01-31-2013 |
20130034615 | LOTION FOR CLEANING HUMAN ANORECTAL AREA - A cleansing lotion composition of zinc derivatives, aloe vera, lanolin and a mixture of water-based emulsifying agents for reducing itchiness, promoting healing and reducing inflammation around the anorectal area of a human subject is disclosed. The subject conveniently spreads a suitable amount of the cleansing lotion placed on toilet paper and applies to the affected anorectal area. The excess lotion could be wiped clean with fresh toilet paper after each application. | 02-07-2013 |
20130039995 | DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE REINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE - Dermatological compositions contain, formulated into a physiologically acceptable medium, at least one retinoid compound selected from among all-trans retinoic acid, isotretinoin, motretinide, and naphthoic acid compounds of formula (I), and salts and esters thereof: | 02-14-2013 |
20130045284 | Methods of Enhancing Skin Hydration and Treating Non-Diseased Skin - Methods of enhancing skin hydration include applying a leave-on moisturizing composition comprising a zinc-containing material and/or a pyrithione material. | 02-21-2013 |
20130045285 | Methods of Enhancing Skin Hydration and Improving Non-Diseased Skin - A method of enhancing skin hydration, the method including applying a rinse-off personal care composition comprising at least one of a zinc-containing material and a pyrithione material to non-diseased skin of an individual. | 02-21-2013 |
20130078317 | ZINC-CONTAINING COMPOSITIONS FOR THE TREATMENT OF DISEASES, ILLNESSES AND SYNDROMES ASSOCIATED WITH EXPOSURE TO PORE FORMING TOXINS - Embodiments of the invention relate to compositions and methods of using the same to treat conditions caused by exposure to a pore-forming toxin. | 03-28-2013 |
20130164386 | Targeting the Alpha3 Subnit of Na+-K+-ATPase for the Treatment of Cough with Sulfenamides - Therapeutic agents that target the alpha3 expressing isozymes of the sodium pump at the peripheral terminals of cough receptors and methods of use thereof to prevent or treat cough are disclosed. | 06-27-2013 |
20130195999 | WOUND DRESSING COMPOSTION AND METHOD OF USE - The present invention provides a non-irritating, sprayable wound dressing composition and a non-irritating, non-sprayable ointment for treating wounds in mammals such as horses or dogs. The composition of the present invention is made of an acceptable carrier and an active ingredient made of organic salts of naturally occurring cations having the capacity to facilitate healing of wounds. | 08-01-2013 |
20130236565 | TOPICAL FORMULATIONS - The present invention is directed towards various topical protective formulations which may be used as an adjunct in preventing the spread of viral type sexually transmitted diseases. The product is intended to be used as a topical lotion, cream, emulsion, or the like. The film forming excipients and active ingredients in the following formulations have demonstrated unique skin protective barrier properties with enhanced persistence that inhibits transmission of viral type sexually transmitted diseases. | 09-12-2013 |
20130309321 | ANTIMICROBIALLY ACTIVE COMPOSITIONS BASED ON ZINC COMPOUND, GLYCERINE MONOALKYL ETHER AND ANTIOXIDANT - Antimicrobial compositions containing (i) at least one zinc compound selected from zinc salt and zinc oxide; (ii) at least one glycerine monoalkyl ether, R—O—CH | 11-21-2013 |
20130330420 | ANIMAL LESION TREATMENT AND PREVENTION FORMULATIONS AND METHODS - An illustrative embodiment of an animal lesion treatment and prevention formulation includes a quantity of water, at least one acid provided in the quantity of water and magnesium sulfate as acid/base buffer mixed in the quantity of water with the at least one acid. In some embodiments, an antimicrobial agent comprising at least one antimicrobial metal salt may be provided in the quantity of water with the at least one acid and the magnesium sulfate. | 12-12-2013 |
20140154338 | SKIN CREAM - A topical composition is provided. The topical composition comprises from about 0.25 to about 1.5 percent by weight hydrocortisone; from about 0.5 to about 5.0 percent by weight lidocaine; and from about 0.25 to about 3.0 percent by weight clotrimazole. | 06-05-2014 |
20140186465 | LOTION FOR CLEANING HUMAN ANORECTAL AREA - A cleansing lotion composition of zinc derivatives, aloe vera, lanolin and a mixture of water-based emulsifying agents for reducing itchiness, promoting healing and reducing inflammation around the anorectal area of a human subject is disclosed. The subject conveniently spreads a suitable amount of the cleansing lotion placed on toilet paper and applies to the affected anorectal area. The excess lotion could be wiped clean with fresh toilet paper after each application. | 07-03-2014 |
20140199413 | MELATONIN AND AN ANTIMICROBIAL OR ANTIBACTERIAL AGENT FOR THE TREATMENT OF ACNE - The invention relates to formulations for topical use comprising an antiseborrheic agent and an antimicrobial and/or antibacterial agent for the treatment of inflammatory dermatoses. In particular said formulations comprise melatonin and an antimicrobial or antibacterial agent, can be used in the pharmaceutical, cosmetic/cosmeceutical or dermatological field and are particularly suitable for the treatment of acne and of the clinical symptoms associated thereto. | 07-17-2014 |
20140220158 | SKIN REJUVENATION CREAM - This invention is based upon the discovery that a mixture of ethyl lactate and isoamyl lactate can be used to improve the penetration of active ingredients in skin care formulations through the outer layers of the stratum corneum and viable epidermis and into the dermis layer of the skin structure. The present invention more specifically discloses a method of rejuvenating skin affected by intrinsic aging and/or photo-induced aging comprising topically applying a topical formulation to the skin, wherein said topical formulation is comprised of ascorbic acid, an amino acid selected from the group consisting of phenylalanine and tyrosine, a non-toxic zinc salt, carnosic acid, α-tocopherol, 0.01 weight percent to 20 weight percent of a mixture of ethyl lactate and isoamyl lactate, wherein the weight ratio of the ethyl lactate to the isoamyl lactate is within the range of 1:10 to 20:1, and a pharmaceutically acceptable carrier. | 08-07-2014 |
20140271921 | PHARMACEUTICAL COMPOSITION - A topical composition comprises at least 5 wt % metronidazole or a pharmacologically acceptable derivative thereof in a non-aqueous vehicle. The composition may be used in the treatment of conditions of the colon, rectum, anorectum and perianal region, in particular inflammatory bowel disease and perianal Crohn's disease. The composition also relieves pain and inflammation and promotes healing of the colon, rectum, anorectum and perianal region following surgical operations. One advantage of the composition is that topical administration of metronidazole results in a primarily local effect and thus side effects observed from systemic administration are avoided. | 09-18-2014 |
20140294992 | HIGHLY STABLE ELECTROLYTIC WATER WITH REDUCED NMR HALF LINE WIDTH - Electrolytic acid or alkaline water having a NMR half line width using 17O of from about 45 to less than 51 Hz, and an oxide reduction potential of from −1000 to +200 mV, or from +600 to +1300 mV, topical compositions that contain such water, uses for such water to hydrate skin, deliver drugs and treat various skin and mucosal conditions, and methods and apparatus for manufacturing the water. | 10-02-2014 |
20140308368 | OPHTHALMOLOGICAL AQUEOUS COMPOSITION - The present invention provides an aqueous ophthalmic composition containing (A) a terpenoid, (B) zinc chloride, and (C) at least one member selected from the group consisting of cellulose-based polymeric compounds, vinyl-based polymeric compounds, polyethylene glycols and dextran. According to the present invention, an aqueous ophthalmic composition is provided in which adsorption of the terpenoid to a container can be inhibited, thereby making it possible to inhibit the reduction in the terpenoid content for a long period of time, the aqueous ophthalmic composition having some excellent actions such as an inhibitory action for histamine release, and an inhibitory action for discharges from the eyes. | 10-16-2014 |
20140377373 | Compositions and Methods for the Prevention of Microbial Infections - Compositions and methods for preventing microbial infections are disclosed. | 12-25-2014 |
20150140121 | Compositions and Methods for Tight Junction Modulation - Compositions and methods for modifying the composition of tight junction complexes and/or improving epithelial barrier function are disclosed. | 05-21-2015 |
20150374875 | ABSORBENT ARTICLE COMPRISING A COOLING SYSTEM - An absorbent article comprising a cooling system, where the cooling system comprises one or more cooling agents which are selected oxalic acid derivatives. The cooling system is stable, does not require special packaging and still provide a cooling sensation even after storage of the products. | 12-31-2015 |
20160045412 | Antifungal, antibacterial topical composition for the prevention and treatment of various skin conditions including diaper rash - A topical, over the counter, all natural, organic, antifungal, antibacterial cream having superior moisturizing and water repellency performance that absorbs into the epidermis without spreading thereby eliminating and preventing the growth of the rash-causing fungus that causes diaper rash, and other skin irritation rashes. | 02-18-2016 |
20160089395 | COMPOSITIONS AND METHODS FOR ALTERING HUMAN CUTANEOUS MICROBIOME TO INCREASE GROWTH OF STAPHYLOCOCCUS EPIDERMIDIS AND REDUCE STAPHYLOCOCCUS AUREUS PROLIFERATION - An antibacterial composition comprising arginine bicarbonate, zinc carbonate, preferably arginine bicarbonate and zinc carbonate (ABZC), in combination, plus one or more physiologically acceptable excipients, administered for the modification of cutaneous microfloras, generally to inhibit the growth of pathogenic | 03-31-2016 |
20160106715 | METHODS TO INHIBIT INFECTION DURING WOUND HEALING WITH TOPICAL COMPOSITIONS INCLUDING AMINO ACIDS - A method that inhibits infection during wound healing by topical application of a single composition, which contacts a wound for a period of time to initiate wound healing. The single composition may include a mixture of all or some of the amino acids including: histidine monohydrochloride monohydrate; isoleucine; leucine; lysine acetate; methionine; phenylalanine; threonine; tryptophan; valine; alanine; arginine acetate; aspartic acid; glutamine; glycine; proline; serine; and tyrosine, which may provide aqueous mixtures of a range of osmolarities or a powdered mixture of amino acids. The single composition may also include any of a carbohydrate, a mixture of fatty acids, vitamins, and mineral nutrients, and another mixture of amino acid derivatives and preservatives. The number of moles of the carbohydrate is less than and proportional to a sum of the number of moles of any mixture of amino acids in the single composition. | 04-21-2016 |
20160113963 | Method, Composition and System for Treatment of Irritations of Skin - A composition and system for the treatment of irritations of the skin includes therapeutically effective amounts of tincture benzoin and zinc oxide; a therapeutically effective amount of Castor oil, used as an epidermal permeation enhancer; and a therapeutically effective amount of petroleum jelly used as a moisturizing agent. | 04-28-2016 |
20160120903 | Topical Relief Cream Formulation for Allergic Reactions to Poison Ivy, Poison Oak, Poison Sumac, Minor Skin Irritations and Insect Bites - A topical relief cream formulation for allergic reactions to poison ivy, poison oak, poison sumac, minor skin irritations and insect bites through chemical means. The relief cream formulation includes a quantity of zinc acetate, a quantity of zinc oxide, a quantity of pramoxine, a quantity of camphor, and a quantity of menthol suspended in a topical lotion base. The aforementioned compounds provide several medicinal properties from analgesic, anesthetic, antiseptic, and astringent categories when applied locally to an area of skin affected by the oils found in poison ivy, poison oak, and poison sumac, as well as, minor skin irritations and insect bites. | 05-05-2016 |
20160151415 | PHARMACEUTICAL COMPOSITION FOR IMPROVING HEALTH, CURE ABNORMALITIES AND DEGENERATIVE DISEASE, ACHIEVE ANTI-AGING EFFECT OF THERAPY AND THERAPEUTIC EFFECT ON MAMMALS AND METHOD THEREOF | 06-02-2016 |
20170231220 | ANTIMICROBIAL COMPOSITION | 08-17-2017 |